Cargando…
Longitudinal analysis of the evolution of cellular immunity to SARS-CoV-2 induced by infection and vaccination
Autores principales: | Vasileiou, Spyridoula, Kuvalekar, Manik, Velazquez, Yovana, Watanabe, Ayumi, Narula, Mansi, Workineh, Aster G., French-Kim, Matthew, Chavez, Alejandro Torres, Gilmore, Sarah, Rooney, Cliona M., Leen, Ann M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Fondazione Ferrata Storti
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10316232/ https://www.ncbi.nlm.nih.gov/pubmed/36373251 http://dx.doi.org/10.3324/haematol.2022.281947 |
Ejemplares similares
-
Allogeneic, Off-the-Shelf, Sars-Cov-2-Specific T Cells to Treat High-Risk Patients with COVID-19
por: Vasileiou, Spyridoula, et al.
Publicado: (2021) -
37. Allogeneic, Off-the-Shelf, SARS-CoV-2-specific T Cells Demonstrate Reactivity Against Emerging Variant Strains
por: Vasileiou, Spyridoula, et al.
Publicado: (2021) -
Using Allogeneic, Off-the-Shelf, Sars-Cov-2-Specific T Cells to Treat High Risk Patients with COVID-19
por: Vasileiou, Spyridoula, et al.
Publicado: (2020) -
Allogeneic, off-the-shelf, SARS-CoV-2-specific T cells (ALVR109) for the treatment of COVID-19 in high-risk patients
por: Vasileiou, Spyridoula, et al.
Publicado: (2022) -
Multi-antigen-targeted T-cell therapy to treat patients with relapsed/refractory breast cancer
por: Hoyos, Valentina, et al.
Publicado: (2022)